© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
648574 |
As an accredited 4-Bromo-6-Chloropyridazin-3(2H)-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-6-Chloropyridazin-3(2H)-One prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of synthetic chemistry, reliable and versatile starting points can change how researchers and manufacturers approach the development of new compounds. Among the unsung yet essential chemicals, 4-Bromo-6-Chloropyridazin-3(2H)-One earns a spot for its role in tough reactions and its knack for stepping up in projects that demand both selectivity and reactivity. This compound stands out from a crowded field of heterocyclic building blocks, and after years working alongside scientists and process chemists, I've seen firsthand the difference that certain reagents can make to both small-scale discovery and larger manufacturing.
The backbone of 4-Bromo-6-Chloropyridazin-3(2H)-One—often recognized by its unique arrangement of bromine and chlorine on a pyridazinone structure—gives it a distinct blend of properties. You end up with a molecule ready to anchor a new pharmaceutical, agrochemical, or specialty material. With a molecular formula of C4H2BrClN2O and a molar mass commonly referenced around 225.43 g/mol, this compound brings both size and electronic influence through its halogen substitutions.
Molecular structure always matters. The bromine at the fourth position and chlorine at the sixth boost reactivity in targeted transformations. That unlocks new pathways in Suzuki and Buchwald-Hartwig cross-couplings. Over my time in the lab, I have seen chemists opt for this compound when a project hits a bottleneck—especially where selective halide chemistry or fine-tuning electronic effects can resolve stubborn reaction stalling.
Physical properties play an everyday role for scientists handling these chemicals. 4-Bromo-6-Chloropyridazin-3(2H)-One tends to show as a crystalline powder, often white to pale yellow. It offers a level of stability suitable for standard laboratory storage, generally at room temperature and away from direct sunlight. These traits reduce unwanted surprises during storage or reaction setup, a small thing but one that matters when so many steps in synthetic chemistry are painstakingly sensitive.
New compounds often mean new challenges, and the tools you select make or break a project. Having spent years in both research and industrial chemistry settings, I am acutely aware that convenience, consistency, and reactivity count for more than marketing gloss. The unique substitution pattern on this pyridazinone ring means you get a very specific combination of reactivity—ideal in multistep syntheses where orthogonality and selectivity are crucial. Unlike simple mono-halogenated analogues, the 4-bromo and 6-chloro substitutions open the door for multiple derivatization strategies, giving chemists more options for downstream modification. The structure’s resonance stabilization lets it hold up to harsher conditions than many other heterocyclic compounds, which extends its usefulness to tougher transformations that other reagents might not tolerate.
For those developing new pharmaceutical intermediates, the need to maintain halogen positions through various reactions stands as a familiar hurdle. This compound does more than pass that test; its stability and the orthogonality of bromo versus chloro groups let you plan, execute, and troubleshoot with less second-guessing. In my experience, many synthetic routes that would stall or fail with less robust starting materials have gone ahead with fewer surprises when this pyridazinone sits at the center of the plan.
Direct comparisons reveal the practical edge. Take, for example, substituting this compound for either a mono-brominated or mono-chlorinated pyridazinone: you lose the ability to differentiate positions, and the stepwise functionalization becomes far less controlled. Classic route flexibility—swapping partners in cross-couplings or installing new groups via nucleophilic substitutions—remains a real advantage. It means fewer detours, lower costs, and less waste, all of which are tallied up in the real world of process development.
It’s easy to underestimate the impact of swapping a single atom on a heterocyclic ring, but practical chemistry tells a different story. In my years synthesizing lead compounds in drug discovery, I relied on analogues of pyridazinones for their role as both intermediates and scaffolds. Comparing 4-Bromo-6-Chloropyridazin-3(2H)-One to more common derivatives like the 4,6-dichloro or the mono-substituted versions, a few things are clear.
Mono-substituted compounds limit follow-up reactions. If only one reactive position is open, strategies for selectivity or late-stage diversification shrink. Dual substitution, especially with bromine and chlorine, injects both reactivity and reliability. Bromine generally serves as a preferred leaving group in palladium-catalyzed reactions, while chlorine remains untouched through more steps. That difference bakes versatility right into the molecule. Dual-halogenation also shifts reactivity patterns, impacting not only what can be attached to the core structure but also influencing how the molecule behaves under a wider spectrum of reaction conditions.
Cost factors matter as well. While heavily substituted analogues might be available, their synthesis can create more waste, require more stringent controls, and sometimes introduce impurities that complicate purification. On the other hand, the 4-bromo and 6-chloro combination makes practical, scalable syntheses more straightforward without pushing up material costs or safety risks. Over time, I've seen manufacturers benefit from this kind of predictability, especially when moving from gram to kilogram scale. Environmental impact, regulatory compliance, and worker safety also factor in, with the lower hazard profiles and predictable reactivity of this compound easing those burdens at each project phase.
Pharmaceutical and agrochemical advances rely on constant innovation, and the right synthetic intermediate forms the linchpin of a successful campaign. Researchers often need to build novel heterocycles that can serve as active pharmaceutical ingredients (APIs), bioactive fragments, or crop protection agents. Over the past decade, the push for new chemotypes has increased demand for intermediates that can keep up with evolving scientific challenges.
4-Bromo-6-Chloropyridazin-3(2H)-One has proven especially valuable for Suzuki-Miyaura cross-coupling, Sonogashira reactions, and other transformations that introduce complex aryl or alkynyl groups. In my own industry collaborations, we have found that the presence of both a bromine and a chlorine on the ring improves the chances of successful functionalization under diverse reaction profiles—one group can undergo coupling reactions cleanly, while the other can be transformed at a later stage, sometimes after preliminary biological screening highlights a promising candidate. This division gives chemists room to maneuver, adapting pathways not only to scientific but also regulatory or intellectual property needs.
For agrochemical developers facing increasing regulatory hurdles and the need for new modes of action, reliable, high-purity intermediates are fundamental. The synthesis and optimization of molecular scaffolds that are both active and selectively modifiable relies on intermediates that do not force unnecessary detours or side reactions. This pyridazinone’s core offers the right balance of reactivity and stability, supporting focused research while reducing material and process costs.
Scalability and handling factor heavily into process decisions, especially when a promising lead advances from bench to pilot plant or manufacturing scale. I have watched more than one project grind to a halt due to an intermediate that just didn’t behave predictably outside the fume hood. 4-Bromo-6-Chloropyridazin-3(2H)-One sidesteps many of those headaches. The compound’s low volatility and high purity profile mean it stays put during transferring and weighing, reducing exposure and contamination worries for technicians and production workers. Its melting point, while not notable compared to some robust benchtop reagents, avoids the pitfall of unexpected phase transitions during controlled heating. taken together, these factors create an overall safer experience in the lab and on the production floor.
Market experience shows this molecule can transition from small-scale test reactions up through larger batches without excessive workarounds. Recrystallization or chromatographic purification yields consistent results, which helps maintain supply chain integrity and reduces delays in fast-paced R&D pipelines. The cost savings from less frequent reprocessing or batch failure outweigh the regular expenses associated with most specialty building blocks.
The biggest value I've seen in 4-Bromo-6-Chloropyridazin-3(2H)-One comes from helping researchers stay focused on discovery, not troubleshooting. While it’s easy to get lost in the search for new compounds with eye-catching activity, the path there is paved with routine repetitive work, and a single roadblock can slow months of experiments. Compounds with the right blend of stability, selectivity, and flexibility free up researchers to test new hypotheses without backtracking to fix chemistry issues at every new idea.
Drug discovery increasingly relies on rapid cycles of design, synthesis, and data analysis. Intermediates that allow orthogonal modifications—altering one position on the scaffold without impacting another—enable medicinal chemists to more easily navigate structure-activity relationships. For antiviral or central nervous system targets where precise modifications affect both activity and pharmacokinetic profiles, flexibility at the molecular level becomes a major asset. This intermediate’s site-selective reactivity gives teams a chance to progress more quickly while exploring diverse chemical space, accelerating the time to reach promising new candidates for further study.
Pure chemistry is only half the battle; environmental and regulatory responsibilities shape decisions about which reagents and intermediates move forward into scale-up. Tightening global regulations on waste, solvent emissions, and worker safety mean every new compound entering a process must withstand scrutiny beyond the lab notebook. The use of bromine and chlorine always raises questions about downstream processing, so the ability to efficiently remove these groups or convert them into benign derivatives is not just a technical curiosity—it helps meet the high bar set by agencies across North America, Europe, and Asia.
I have seen sustainability teams prioritize intermediates with predictable breakdown products and manageable waste disposal pathways. With 4-Bromo-6-Chloropyridazin-3(2H)-One, the track record supports responsible scale-up. Byproducts and spent materials stemming from its use align with established treatment streams, whether through chemical neutralization, controlled incineration, or solvent reclamation. That translates to fewer surprises during permit application or environmental review, reducing administrative and operational headaches later in development.
On the worker safety front, the compound’s crystalline nature and relatively low dusting properties decrease accidental exposure from spills or airborne particles, compared to lighter or more volatile reagents. Standard personal protective equipment suffices for handling, and its chemical resilience lets it stay shelf-stable much longer than many other intermediates. That stability keeps both researchers and manufacturing workers safer over a compound’s lifecycle.
The global supply chain for fine chemicals faces tests on quality and consistency. Sudden spikes in demand—spurred by patent cliffs, rapid agricultural reforms, or the pivot to greener chemistries—put pressure on producers and procurement teams. One key to a stable project is knowing that your core intermediates arrive on time, with every batch meeting the same rigorous standards. Over my career, I have seen disruptions in supply grounding projects at critical moments. 4-Bromo-6-Chloropyridazin-3(2H)-One, due partly to its established place in both pharmaceutical and agrochemical industries, tends to remain consistently available even during heightened demand. The underlying synthetic routes leverage well-understood halogenation and ring-closing methodologies, which can be adapted to local raw materials if needed. That means users aren’t locked out by geopolitics or sourcing shifts, a crucial point for large organizations managing multiple projects around the globe.
Bulk packaging, purity profiles, and compatibility with standard solvents make storage, transport, and integration into automated systems almost routine. While newer, “designer” intermediates sometimes promise breakthrough reactivity, the classics maintain their superiority through reliability and logistical simplicity. With strong documentation, batch tracking, and third-party testing, buyers secure both traceability and peace of mind—not an abstract selling point, but a daily necessity for compliance officers and lead chemists alike.
Over the past decade, case histories have shown how the right early choice of intermediate transforms timelines and outcomes. In developing kinase inhibitors for oncology, chemists tasked with installing heterocyclic moieties in challenging molecular architectures turned to 4-Bromo-6-Chloropyridazin-3(2H)-One for both its compatibility with diverse catalysts and its ability to undergo late-stage diversification. The outcome: more analogues synthesized, better SAR progression, and a faster move into in vivo studies, without delays tied to sourcing or inconsistent reactivity.
In the world of crop protection, research teams racing to develop actives that overcome resistance looked for scaffolds that allowed rapid iteration. Dual-halogenated pyridazinones shortened the pathway to broad chemical libraries, supporting the discovery of new herbicidal and fungicidal candidates. Lessons from these projects reinforce the point that predictable intermediates source not only efficiency but also enable tightly managed intellectual property strategies, since more diverse analogues can stem from the same synthetic framework.
Even the best intermediates come with challenges: resource sourcing, environmental regeneration, and optimized manufacturing conditions. Sustainable chemistry goals mean every supplier and end user must weigh process intensification, waste minimization, and safety throughout a compound’s life. 4-Bromo-6-Chloropyridazin-3(2H)-One already fares better than many alternatives, but pressure remains to further reduce process mass intensity, push for lower solvent usage, and integrate green chemistry metrics from the ground up.
One solution rests in tighter integration between supplier and end user: clear communication channels for specification changes or improvements, flexible lot sizing, and open sharing of process analytics. Advanced modeling and data-driven approaches now support ongoing optimizations, so continual feedback loops between formulators, synthetic chemists, and quality assurance professionals form the foundation for next-generation manufacturing. Off-the-shelf intermediates can improve with tailored impurity profiles or controlled particle sizing, built on direct industry input rather than one-size-fits-all production models.
Capitalize on innovation wherever possible. Renewable bromine and chlorine sources, solvent minimization in halogenation steps, and investment in continuous flow production all offer incremental gains. Decision-makers should evaluate metrics beyond yield or cost: waste reduction, time savings, and documentation quality matter just as much. Experience shows that when suppliers commit to continuous improvement, supported by strong customer engagement, the industry moves toward a more sustainable and efficient future with every intermediate produced.
Seasoned chemists and newcomers alike know that choosing the right intermediate in synthetic design impacts everything downstream. 4-Bromo-6-Chloropyridazin-3(2H)-One stands out among a crowded field not just because of its chemical structure, but because it solves the real-world problems that bench scientists and production teams face every day. Its performance in the lab, reliability in procurement, and compatibility with established and emerging methodologies all add up to a compound that continues to earn trust.
Innovation rarely hinges on a single ingredient, but progress depends on decisions made at every step. The right starting materials put advanced research within reach, cutting through both technical and operational barriers. Over years of experience across discovery and development, I have found that every project benefits from robust, flexible, and trustworthy intermediates. For those pushing the boundaries of pharmaceuticals, crop science, and specialty chemicals, 4-Bromo-6-Chloropyridazin-3(2H)-One deserves its role as a staple of modern synthetic chemistry.
